Skip to main content
NCBI home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1960 May;151(2):272–284. doi: 10.1113/jphysiol.1960.sp006437

The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice

H Blaschko, T L Chruściel
PMCID: PMC1363237  PMID: 13801347

Full text

PDF
272

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLASCHKO H., BURN J. H., LANGEMANN H. The formation of noradrenaline from dihydroxyphenylserine. Br J Pharmacol Chemother. 1950 Sep;5(3):431–437. doi: 10.1111/j.1476-5381.1950.tb00593.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BLASCHKO H. The development of current concepts of catecholamine formation. Pharmacol Rev. 1959 Jun;11(2 Pt 2):307–316. [PubMed] [Google Scholar]
  3. Blaschko H., Holton P., Stanley G. H. Enzymic formation of pressor amines. J Physiol. 1949 Jun 15;108(4):427–439. doi: 10.1113/jphysiol.1949.sp004346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blaschko H. The activity of l(-)-dopa decarboxylase. J Physiol. 1942 Nov 30;101(3):337–349. doi: 10.1113/jphysiol.1942.sp003988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CARLSSON A., LINDQVIST M., MAGNUSSON T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957 Nov 30;180(4596):1200–1200. doi: 10.1038/1801200a0. [DOI] [PubMed] [Google Scholar]
  6. GADDUM J. H., VOGT M. Some central actions of 5-hydroxytryptamine and various antagonists. Br J Pharmacol Chemother. 1956 Jun;11(2):175–179. doi: 10.1111/j.1476-5381.1956.tb01049.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HOLTZ P. Role of L-DOPA decarboxylase in the biosynthesis of catecholamines in nervous tissue and the adrenal medulla. Pharmacol Rev. 1959 Jun;11(2 Pt 2):317–329. [PubMed] [Google Scholar]
  8. HOLTZ P., WESTERMANN E. Uber die Dopadecarboxylase und Histidindecarboxylase des Nervengewebes. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1956;227(6):538–546. [PubMed] [Google Scholar]
  9. MITOMA C., POSNER H. S., BOGDANSKI D. F., UDENFRIEND S. Biochemical and pharmacological studies on o-tyrosine and its meta and para analogues; a suggestion concerning phenylketonuria. J Pharmacol Exp Ther. 1957 Jun;120(2):188–194. [PubMed] [Google Scholar]
  10. RAAB W., GIGEE W. Concentration and distribution of "encephalin" in the brain of humans and animals. Proc Soc Exp Biol Med. 1951 Jan;76(1):97–100. doi: 10.3181/00379727-76-18398. [DOI] [PubMed] [Google Scholar]
  11. ROTHBALLER A. B. The effects of catecholamines on the central nervous system. Pharmacol Rev. 1959 Jun;11(2 Pt 2):494–547. [PubMed] [Google Scholar]
  12. SCHMITERLOW C. G. The formation in vivo of noradrenaline from 3:4-dihydroxyphenylserine (noradrenaline carboxylic acid). Br J Pharmacol Chemother. 1951 Mar;6(1):127–134. doi: 10.1111/j.1476-5381.1951.tb00628.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SLOANE-STANLEY G. H. Amino acid decarboxylases of rat liver. Biochem J. 1949;45(5):556–559. doi: 10.1042/bj0450556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SOURKES T. L. Substrate specificity of hydroxy-l-phenyl-alanine decarboxylases and related enzymes. Rev Can Biol. 1955 Mar;14(1):49–63. [PubMed] [Google Scholar]
  15. WEIL-MALHERBE H., AXELROD J., TOMCHICK R. Blood-brain barrier for adrenaline. Science. 1959 May 1;129(3357):1226–1227. doi: 10.1126/science.129.3357.1226. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES